The Emphasis Tech Talks Podcast with Host David Clausen

Convincing the skeptics is part of the journey. From skepticism to adoption, the road to innovation is paved with challenges. Paul Mastoridis, Pharm.D., CEO of Adherium, shares the challenges of introducing new medical technology to physicians on the latest episode of Emphasis Tech Talks hosted by David Clausen. It's not just about innovation; it's about proving value through data and clinical trials. Tune into Emphasis Tech Talks to learn how Adherium is overcoming these hurdles and transforming healthcare here: https://lnkd.in/e7aF-hui #FutureofHealthcare #SeamlessTechnology #MedTech #Innovation #Healthcare #DataDriven #ClinicalTrials

"AI will not replace physicians, but it will replace physicians without AI." Paul Mastoridis, Pharm.D., CEO of Adherium, drops a powerful truth bomb on Emphasis Tech Talks hosted by David Clausen. In the age of AI, embracing technology is not just an option, it's essential for physicians to stay ahead. Hear how AI is empowering doctors to make better decisions, deliver more personalized care, and ultimately, improve patient outcomes. Make sure not to miss out the full episode here: https://lnkd.in/e7aF-hui #DataDrivenHealthcare #AI #AIinHealthcare #FutureofMedicine #PhysicianEmpowerment #MedTech #Innovation

The right diagnosis is the first step to the right treatment. Paul Mastoridis, Pharm.D. highlights the critical importance of accurate and timely diagnoses for asthma and COPD patients. Adherium's technology is empowering doctors to make informed decisions faster and more efficiently, leading to better patient outcomes. Listen to the full conversation on Emphasis Tech Talks hosted by David Clausen here: https://lnkd.in/e7aF-hui #Healthcare #PatientCare #Accuracy #Efficiency #Technology #Asthma #COPD #Diagnosis #MedTech #Innovation

1,000 patients a month? It sounds like a dream, but with AI, it's becoming a reality for respiratory therapists. Paul Mastoridis, Pharm.D. shares how AI is amplifying their impact, allowing them to manage larger caseloads without compromising on quality. It's a win-win for both therapists and patients. Tune in to Emphasis Tech Talks with David Clausen to discover how this technology is transforming the field and making healthcare more accessible. Check out the full episode here: https://lnkd.in/e7aF-hui #AIRevolution #Healthcare #Efficiency #Scalability #FutureofMedicine #RespiratoryTherapy #MedTech #Innovation #PatientAccess

Just like Apple keeps innovating, so does Adherium! On Emphasis Tech Talks to hear with David Clausen, Paul Mastoridis, Pharm.D., CEO of Adherium, shares the company's relentless pursuit of progress in respiratory care. From simple time-date stamps to sophisticated flow rate measurements, their devices have evolved to meet patients' needs and outsmart those sneaky canister tricks! Listen to the full story here: https://lnkd.in/e7aF-hui #Healthcare #DataDriven #DigitalHealth #TechTalks #MedTech #Innovation #PatientCare #Asthma #COPD

Imagine a world where asthma attacks are no longer a terrifying surprise. David Clausen sits down with Paul Mastoridis, Pharm.D., the visionary CEO of Adherium, as he reveals how their groundbreaking technology is turning that dream into reality. By harnessing the power of AI and real-time data from smart inhalers, Adherium can predict exacerbations days before they strike. This means early intervention, proactive treatment, and fewer trips to the ER. Tune in to Emphasis Tech Talks to discover how this revolutionary approach is transforming asthma management and empowering patients to breathe easier here: https://lnkd.in/e7aF-hui #Asthma #COPD #PredictiveAnalytics #AIinHealthcare #HealthTech #DataScience #PatientEmpowerment #PreventiveCare #DigitalHealth

Rescue inhalers are a lifeline for many, but overuse can signal a brewing storm. Paul Mastoridis, Pharm.D., CEO of Adherium, sheds light on the alarming link between frequent rescue inhaler use and impending asthma attacks. He explains how their innovative technology is addressing this critical issue by monitoring inhaler usage and identifying patients at risk. By providing real-time feedback and personalized support, they're helping individuals take control of their health and achieve better outcomes. Join Paul and David Clausen on Emphasis Tech Talks to explore the future of proactive healthcare here: https://lnkd.in/e7aF-hui #Asthma #COPD #RespiratoryHealth #MedicationAdherence #PatientEmpowerment #HealthTech #AsthmaManagement #COPDManagement

Empowering patients, one breath at a time. Say goodbye to guesswork in managing asthma and COPD! Adherium's Hailie devices provide real-time insights into medication usage, empowering patients and physicians to make informed decisions. A very smart inhalers equipped with 5 sensors that track everything from shaking to inhalation. Hear Paul Mastoridis, Pharm.D. explain how this technology is transforming respiratory care on the latest Emphasis Tech Talks hosted by David Clausen. Get a glimpse into the future of respiratory care here: https://lnkd.in/e7aF-hui #AdvancedTechnology #SmartInhalers #FutureofHealthcare #TechInnovation #Asthma #COPD #DigitalHealth #MedTech #Innovation

The statistics are alarming: countless lives are lost due to poor medication adherence BUT what if AI could change that? Join David Clausen and special guest Paul Mastoridis, Pharm.D. takes us on Adherium's incredible journey, from conducting clinical trials to becoming a leading commercial company transforming respiratory care. Discover how their innovative blend of AI, data-driven insights, and cutting-edge technology is revolutionizing patient care and shaping the future of medicine. New episode of Emphasis Tech Talks is out now: https://lnkd.in/e7aF-hui #HealthcareInnovation #DataScience #FutureofMedicine #AI #Tech #Asthma #COPD #MedicationAdherence

Thank you Daniel Faber, for agreeing to join us on the PodCast.